Heron Therapeutics HRTX
NASDAQ HRTX
$0.31 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Research & Development (2010 - 2026)

Updated

Heron Therapeutics' Research & Development came in at $2.7 million for Q2 2026, down 7.9% from $2.93 million a year earlier but up 13.3% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Heron Therapeutics reported Research & Development of $12.3 million, down 4.3% year-over-year; for FY2025, it was $12.43 million, down 25.5% from FY2024.

  • Research & Development has declined in each of the last five years, with a five-year compound annual growth rate of -41.0% (FY2020 to FY2025).
  • Going back by year, Research & Development was $16.68 million in FY2024 (-57.4%), $39.13 million in FY2023 (-52.7%), $82.7 million in FY2022 (-36.8%) and $130.82 million in FY2021 (-25.0%).
  • The five-year range for quarterly Research & Development is -$13.75 million (Q4 2022) to $42.07 million (Q1 2022).
  • Year-over-year, Research & Development increased in two of the last eight quarters, with an average decline of 25.4%.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2025 (growth of 17.9%), and the weakest in Q1 2023 (a decline of 79.0%).
  • Business Quant data shows HRTX's Research & Development at $2.39 million (Q1 2026), $3.75 million (Q4 2025) and $3.47 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 3.65 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.34 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -4.05 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.76 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 993.80 Mn
10 Heron Therapeutics 58.85 Mn -130.71 Mn 26.09 Mn 2.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.70 Mn
Mar 31, 2026 2.39 Mn
Dec 31, 2025 3.75 Mn
Sep 30, 2025 3.47 Mn
Jun 30, 2025 2.93 Mn
Mar 31, 2025 2.28 Mn
Dec 31, 2024 3.18 Mn
Sep 30, 2024 4.47 Mn
Jun 30, 2024 4.43 Mn
Mar 31, 2024 4.61 Mn
Dec 31, 2023 7.80 Mn
Sep 30, 2023 9.29 Mn
Jun 30, 2023 13.21 Mn
Mar 31, 2023 8.84 Mn
Dec 31, 2022 -13.75 Mn
Sep 30, 2022 25.55 Mn
Jun 30, 2022 28.83 Mn
Mar 31, 2022 42.07 Mn
Dec 31, 2021 28.88 Mn
Sep 30, 2021 28.60 Mn
API Access

Heron Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=HRTX&period=max&api_key=YOUR_API_KEY